导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.65% | 1841/4773 |
| 近一周 | 0.20% | 122/5462 |
| 近一月 | 2.83% | 213/5421 |
| 近一季 | 3.25% | 376/5209 |
| 近半年 | -3.64% | 2272/4920 |
| 近一年 | 0.71% | 2497/4366 |
| 近两年 | 18.77% | 2668/2954 |
| 近三年 | 23.22% | 1355/2253 |
| 成立以来 | 76.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.12% 804/4961 |
-11.42% 4284/5312 |
- - |
- - |
| 2025 | -2.00% 3335/4813 |
-2.73% 2971/3635 |
3.19% 1120/4076 |
-4.12% 4020/4524 |
1.83% 1197/4813 |
| 2024 | 27.31% 196/3463 |
9.24% 140/2808 |
4.62% 203/3014 |
10.77% 2594/3129 |
0.56% 1198/3463 |
| 2023 | 14.36% 44/2656 |
7.66% 543/2280 |
5.71% 60/2385 |
3.57% 181/2515 |
-2.99% 566/2655 |
| 2022 | -1.75% 50/2207 |
0.29% 113/1919 |
-1.02% 1666/2016 |
-5.46% 78/2113 |
4.69% 520/2208 |
| 2021 | 10.02% 446/1822 |
7.48% 71/1255 |
-2.85% 1228/1330 |
5.19% 288/1466 |
0.17% 1164/1822 |
| 2020 | 3.22% 913/1250 |
-10.83% 804/1028 |
1.06% 995/1067 |
10.81% 511/1164 |
3.37% 918/1184 |
| 2019 | - - |
- - |
- - |
- - |
5.47% 715/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 嘉实沪深300红利低波动ETF VS. 长安沪深300非周期A(740101) |